Daniel Nguyen, MD
Anesthesiology · Duarte, CANPI 1750469565
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by AbbVie at 40.6% of the total. 2023 is the largest year on record at $200, more than ten times the $20 reported in 2019.
Across 11 payments — averaging $33.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$150
- Daiichi Sankyo Inc.$140
- Chiesi USA, Inc.$22
- Merck$21
- Dendreon Pharmaceuticals LLC$20
- Idorsia Pharmaceuticals US Inc$17
Across 54 payments — averaging $25,448 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Blueprint Medicines Corporation$882K
- Janssen Research & Development, LLC$453K
- Novartis$39K
What the payments were for
- Food & beverage$370100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $150 |
| Daiichi Sankyo Inc. | 1 | $140 |
| Chiesi USA, Inc. | 1 | $22 |
| Merck | 1 | $21 |
| Dendreon Pharmaceuticals LLC | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enhertu$140
How this compares
$370 in reported general payments places this provider in the 75th percentile of 5,717 anesthesiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in Duarte
- Michael LewDuarte$151K
- Chang Hwa Mary ChenDuarte$94K
- Jack JengSouth San Francisco$1.3M
- Roger PhillipsChico$434K
- David DeyhimyLaguna Hills$344K
- Maxime CannessonLos Angeles$336K
- Alexander RoherSan Diego$282K
- Moody MakarLos Angeles$252K
- Jonathan JahrLos Angeles$223K
- Amir ShbeebLong Beach$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.